β¨ Medicines Distribution Consent
4368 NEW ZEALAND GAZETTE No. 134
Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name
(if any)
Bupivacaine hydrochloride monohydrate 1.32 mg/mL (equivalent to 1.25 mg/mL anhydrous Bupivacaine hydrochloride) and Fentanyl citrate 7.8 mcg/mL (equivalent to 5 mcg/mL Fentanyl) in 20 mL | Solution for epidural injection (vial) | Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia | Marcain with Fentanyl injection
Bupivacaine hydrochloride monohydrate 1.32 mg/mL (equivalent to 1.25 mg/mL anhydrous Bupivacaine hydrochloride) and Pethidine hydrochloride 2.5 mg/mL in 20 mL | Solution for epidural injection (vial) | Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia | Marcain with Pethidine injection
Tropisetron hydrochloride 5.64 mg (equivalent to 5 mg tropisetron) in 20 mL | Capsule | Sandoz Pharma Limited, Basle, Switzerland | Navoban
Tropisetron hydrochloride 5.64 mg (equivalent to 5 mg tropisetron) | Injection (ampoules) | Sandoz Pharma Limited, Basle, Switzerland | Navoban
Follitropin beta 100IU and sodium chloride 4.5 mg/mL in 1 mL as diluent | Powder for injection (ampoules) | Organon (Ireland) Limited, Swords, Co. Dublin, Ireland and Organon International BV, Oss, The Netherlands | Puregon 100
Follitropin beta 150IU and sodium chloride 4.5 mg/mL in 1 mL as diluent | Powder for injection (ampoules) | Organon (Ireland) Limited, Swords, Co. Dublin, Ireland and Organon International BV, Oss, The Netherlands | Puregon 150
Follitropin beta 50IU and sodium chloride 4.5 mg/mL in 1 mL as diluent | Powder for injection (ampoules) | Organon (Ireland) Limited, Swords, Co. Dublin, Ireland and Organon International BV, Oss, The Netherlands | Puregon 50
Follitropin beta 75IU and sodium chloride 4.5 mg/mL in 1 mL as diluent | Powder for injection (vials) | Organon (Ireland) Limited, Swords, Co. Dublin, Ireland and Organon International BV, Oss, The Netherlands | Puregon 75
Valaciclovir hydrochloride 556 mg (equivalent to 500 mg valaciclovir), 1112 mg (equivalent to 1000 mg valaciclovir) | Tablets | Wellcome Foundation Limited, Temple Hill, Dartford, Kent, United Kingdom | Valaciclovir
Valaciclovir hydrochloride 556 mg (equivalent to 500 mg valaciclovir), 1112 mg (equivalent to 1000 mg valaciclovir) | Tablets | Wellcome Foundation Limited, Temple Hill, Dartford, Kent, United Kingdom | Valtrex
Dated this 8th day of November 1995.
KAREN O. POUTASI, Director-General of Health, pursuant to delegation given by the Minister of Health on 25 June 1993.
607518
Consent to the Distribution of Changed Medicines
Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:
Schedule
Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name
(if any)
Somatropin, recombinant human 12IU and Benzyl alcohol 0.9% in 3 mL as diluent | Powder for injection (vial) and diluent (vial) | Novo Nordisk A/S., Gentofte, Denmark | Norditropin 12IU
Somatropin, recombinant human 12IU and Benzyl alcohol 0.9% in 2 mL as diluent | Powder for injection (vial) and diluent (cartridge) | Novo Nordisk A/S., Gentofte, Denmark | Norditropin Penset 12
Somatropin, recombinant human 24IU and Benzyl alcohol 0.9% in 2 mL as diluent | Powder for injection (vial) and diluent (cartridge) | Novo Nordisk A/S., Gentofte, Denmark | Norditropin Penset 24
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1995, No 134
NZLII —
NZ Gazette 1995, No 134
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare8 November 1995
Medicines, Distribution, Consent, Medicines Act 1981
- KAREN O. POUTASI, Director-General of Health
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social WelfareMedicines, Distribution, Consent, Medicines Act 1981